Browse by author
Lookup NU author(s): Dr Lu Wang,
Dr Guy MacGowanORCiD,
Professor Simi Ali,
Professor John Dark
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020 International Society for Heart and Lung TransplantationDespite the advancements in medical treatment, mechanical support, and stem cell therapy, heart transplantation remains the most effective treatment for selected patients with advanced heart failure. However, with an increase in heart failure prevalence worldwide, the gap between donor hearts and patients on the transplant waiting list keeps widening. Ex situ machine perfusion has played a key role in augmenting heart transplant activities in recent years by enabling the usage of donation after circulatory death hearts, allowing longer interval between procurement and implantation, and permitting the safe use of some extended-criteria donation after brainstem death hearts. This exciting field is at a hinge point, with 1 commercially available heart perfusion machine, which has been used in hundreds of heart transplantations, and a number of devices being tested in the pre-clinical and Phase 1 clinical trial stage. However, no consensus has been reached over the optimal preservation temperature, perfusate composition, and perfusion parameters. In addition, there is a lack of objective measurement for allograft quality and viability. This review aims to comprehensively summarize the lessons about ex situ heart perfusion as a platform to preserve, assess, and repair donor hearts, which we have learned from the pre-clinical studies and clinical applications, and explore its exciting potential of revolutionizing heart transplantation.
Author(s): Wang L, MacGowan GA, Ali S, Dark JH
Publication type: Article
Publication status: Published
Journal: Journal of Heart and Lung Transplantation
Online publication date: 13/10/2020
Acceptance date: 02/04/2016
ISSN (print): 1053-2498
ISSN (electronic): 1557-3117
Publisher: Elsevier Inc.
Altmetrics provided by Altmetric